Aging, prospective memory, and health-related quality of life in HIV infection

AIDS and Behavior

Volumn 16, Issue 8, 2012, Pages 2309-2318

  Doyle, Katie ^a   Weber, Erica ^b   Atkinson, J Hampton ^a   Grant, Igor ^a   Woods, Steven Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Aging; AIDS dementia complex; Functional status; Health status; Prospective memory; Quality of life

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; AGING; ARTICLE; COHORT ANALYSIS; EPISODIC MEMORY; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTOR; SELF REPORT; SOCIOECONOMICS; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CALIFORNIA; COHORT STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTORS; SELF REPORT; SOCIOECONOMIC FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84868573606     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0121-x     Document Type: Article

References (68)

1. Centers for Disease Control. HIV/AIDS surveillance report, 2005. Atlanta: US Department of Health and Human Services, CDC; 2007. p. 1-63.
2. Smith G. Statement of Senator Gordon H. Smith. Aging hearing: HIV over fifty, exploring the new threat. Washington, DC: Senate Committee on Aging. http://www.gpo.gov/congress/senate/senate22sh109.html
3. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815-26.
4. Piette J, Wachtel TJ, Mor V, Mayer K. The impact of age on the quality of life in persons with HIV infection. J Aging Health. 1995;7(2):163-7.
5. Zahran HS, Kobau R, Moriarty DG, et al. Health-related quality of life surveillance - United States, 1993-2002. MMWR Surveill Summ. 2005;54:1-35.
6. Chesney MA, Chambers DB, Taylor JM, Johnson LM. Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndr. 2003;33(Suppl 2): S185-93.
7. Avis NE, Smith KW. Quality of life in older adults with HIV disease. Res Aging. 1998;20(6):822-45.
8. Hays RB, Catania JA, McKusick L, Coates TJ. Help-seeking for AIDS-related concerns: a comparison of gay men with various HIV diagnoses. Am J Community Psychol. 1990;18(5):743-55.
9. Fleishman JA, Sherbourne CD, Crystal S, et al. Coping, conflictual social interactions, social support, and mood among HIV-infected persons. HCSUS consortium. Am J Community Psychol. 2000;28(4):421-53.
10. Swindells S, Mohr J, Justis JC, et al. Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS. 1999; 10(6):383-91.
11. Schmitz MF, Crystal F. Social relations, coping, and psychological distress among persons with HIV/AIDS. J Appl Soc Psychol. 2000;30(4):665-85.
12. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3-16.
13. Heaton RK, Franklin D, Clifford D, et al. Persistence and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: the CHARTER study. J Neurovirol. 2009; 15(Suppl 1):34-5.
14. Becker JT, Lopes OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18:S11-8.
15. Larussa D, Lorenzini P, Cingolani A, et al. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1 infected patients. AIDS Res Hum Retroviruses. 2006;22:386-92.
16. Valcour B, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV cohort. Neurology. 2004;63:822-7.
17. Valcour B, Shikuma C, Shiramizu B, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii HIV with aging cohort. J Neuroimmunol. 2004;157:197-202.
18. Cherner M, Ellis RJ, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004;18(Suppl 1):S27-34.
19. Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007;13(3): 203-9.
20. Sacktor N, Skolasky RL, Cox C, et al. Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol. 2010; 16(5):335-41.
21. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152-68.
22. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40-9.
23. Ettenhofer ML, Foley J, Behdin N, Levine AJ, Castellon SA, Hinkin CH. Reaction time variability in HIV-positive individuals. Arch Clin Neuropsychol. 2010;25(8):791-8.
24. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200-9.
25. Tozzi V, Balestra P, Galgani S, et al. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses. 2003;19(8):643-52.
26. Osowiecki DM, Cohen RA, Morrow KM, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14(10):1327-32.
27. Zogg JB, Woods SP, Weber E, Doyle K, Grant I, the HNRC Group. Are time-and event-based prospective memory comparably affected in HIV infection? Arch Clin Neuropsychol. 2011; 26:250-9.
28. Gupta S, Woods SP, Weber E, Dawson MS, Grant I, The HNRC Group. Is prospective memory a dissociable cognitive function in HIV infection? J Clin Exp Neuropsychol. 2010;32(8):898-908.
29. Woods SP, Morgan EE, Marquie-Beck J, et al. Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol. 2006; 19(4):217-21.
30. Woods SP, Carey CL, Moran LM, et al. Frequency and predictors of self-reported memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 2007;22(2):187-95.
31. Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I, The HNRC Group. Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol. 2006;28(4):536-48.
32. Martin EM, Nixon H, Pitrack DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substancedependent individuals: preliminary observations. J Clin Exp Neuropsychol. 2007;29(5):496-504.
33. Weber E, Woods SP, Delano-Wood L, et al. An examination of the age-prospective memory paradox in HIV-infected adults. J Clin Exp Neuropsychol. 2011;33(10):1108-18.
34. Woods SP, Dawson, Weber E, Grant I, The HNRC Group. The semantic relatedness of cue-intention pairings influence eventbased prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol. 2010;32(4):398-407.
35. Woods SP, Iudicello JE, Moran LM, et al. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110-7.
36. Contardo C, Black AC, Beauvais J, Dieckhaus K, Rosen MI. Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol. 2009;24:547-54.
37. Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23(3):257-70.
38. Woods SP, Dawson MS, Weber E, et al. Timing is everything: antiretroviral non-adherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009; 15(1):42-52.
39. Woods SP, Weber E, Weisz M, Twamley EW, Grant I, The HNRC Group. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011;56(1):77-84.
40. Center for Disease Control. HIV/AIDS surveillance report, 2007. Atlanta: US Department of Health and Human Services, CDC; 2009. p. 1-54.
41. Stoff DM. Mental health research in HIV/AIDS and aging: problems and prospects. AIDS. 2004;18(Suppl 1):S3-10.
42. The Psychological Corporation. Manual for the Wechsler Test of Adult Reading (WTAR). San Antonio: Author; 2001.
43. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
44. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
45. Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center; 1994.
46. Lamping DL. Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection. Psychol Health. 1994;9(1-2):31-49.
47. Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparision of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14(1):141-50.
48. Woods SP, Moran LM, Dawson MS, Carey CL, Grant I, the HNRC Group. Psychometric characteristics of the memory for intentions screening test. Clin Neuropsychol. 2008;22(5):864-78.
49. Raskin S, Buckheit C, Sherrod C. Memory for intentions test (MIsT). Lutz: Psychological Assessment Resources, Inc.; 2010.
50. Smith G, Della Sala S, Logie RH, Maylor EA. Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory. 2000;8(5):311-2.
51. Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH. The prospective and retrospective memory questionnaire (PRMQ): normative data and latent structure in a large non-clinical sample. Memory. 2003;11(3):261-75.
52. Smith HJ, Taylor R, Mitchell A. A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart. 2000;84(4):390-4.
53. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789-99.
54. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychology Press; 1985.
55. Woods SP, Carey CL, Tröster AI, Grant I, The HNRC Group. Action (verb) generation in HIV-1 infection. Neuropsychologia. 2005;43(8):1144-51.
56. Delis DC, Kramer JH, Kaplan E, Ober BA. The California verbal learning test. 2nd ed. San Antonio: The Psychological Corporation; 2000.
57. Culbertson WC, Zillmer EA. The Tower of London DX (TOLDX) manual. North Tonawanda: Multi-Health Systems; 2001.
58. Psychological Corporation. WAIS-III and WMS-III technical manual. San Antonio: Author; 1997.
59. Kløve H. Grooved pegboard. Indiana: Lafayette Instruments; 1963.
60. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759-78.
61. World Health Organization. Composite international diagnostic interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.
62. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author; 1994.
63. McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego: Educational and Industrial Testing Services; 1981.
64. Kliegel M, Jager T, Altgasen M, Shum D. Clinical neuropsychology of prospective memory. In: Kliegel M, McDaniel MA, Einstein GO, editors. Prospective memory: cognitive, neuroscience, developmental, and applied perspectives. New York: Taylor and Francis Group/Lawrence Erlbaum Associates; 2008. p. 283-308.
65. Wilson IB, Cleary PD. Linking clinical variables with healthrelated quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59-65.
66. Dijkers MP. Quality of life after traumatic brain injury: a review of research approaches and findings. Arch Phys Med Rehabil. 2004;85(4 Suppl 2):S21-35.
67. Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse. 2003;29(2):323-35.
68. Holloway F, Carson J. Quality of life in severe mental illness. Int Rev Psychiatry. 2002;14(3):175-84.